Wealth Advisory Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$708K Buy
25,231
+1,336
+6% +$35.6K 0.16% 80
2025
Q4
$595K Sell
23,895
-4,083
-15% -$103K 0.14% 79
2025
Q3
$713K Buy
27,978
+470
+2% +$11.6K 0.17% 81
2025
Q2
$667K Buy
27,508
+129
+0.5% +$3.01K 0.17% 80
2025
Q1
$694K Buy
27,379
+664
+2% +$17.4K 0.18% 77
2024
Q4
$709K Sell
26,715
-143
-0.5% -$3.88K 0.2% 69
2024
Q3
$777K Buy
26,858
+5,117
+24% +$149K 0.21% 68
2024
Q2
$608K Buy
21,741
+3,368
+18% +$92.7K 0.16% 74
2024
Q1
$510K Buy
18,373
+3,058
+20% +$84.9K 0.13% 80
2023
Q4
$441K Sell
15,315
-20,334
-57% -$615K 0.15% 59
2023
Q3
$1.12M Buy
35,649
+14,048
+65% +$497K 0.22% 68
2023
Q2
$792K Sell
21,601
-10,646
-33% -$414K 0.21% 68
2023
Q1
$1.32M Sell
32,247
-29,701
-48% -$1.28M 0.35% 62
2022
Q4
$3.17M Sell
61,948
-6,690
-10% -$321K 0.85% 36
2022
Q3
$3M Sell
68,638
-2,461
-3% -$120K 0.83% 41
2022
Q2
$3.73M Sell
71,099
-397
-0.6% -$20.2K 0.92% 40
2022
Q1
$3.7M Buy
+71,496
New +$3.71M 0.77% 45
2021
Q3
$2.5M Buy
58,115
+30,525
+111% +$1.35M 0.56% 48
2021
Q2
$1.08M Sell
27,590
-16,900
-38% -$657K 0.26% 85
2021
Q1
$624K Buy
44,490
+20,145
+83% +$715K 0.47% 41
2020
Q4
$896K Sell
24,345
-2,914
-11% -$107K 0.24% 69
2020
Q3
$949K Buy
27,259
+1,146
+4% +$40.2K 0.25% 84
2020
Q2
$810K Buy
26,113
+1,693
+7% +$57.5K 0.23% 88
2020
Q1
$756K Sell
24,420
-4,239
-15% -$144K 0.26% 86
2019
Q4
$1.06M Buy
+28,659
New +$1.02M 0.28% 84

Other funds holding PFE

Wealth Advisory Solutions's PFE Position: Q1 2026 in Review

Wealth Advisory Solutions increased its Pfizer (PFE) stake by 5.6% in Q1 2026, buying an estimated $35.6K and bringing the position to 25,231 shares worth $708K. The position accounts for 0.16% of the portfolio, ranked #80.

Wealth Advisory Solutions first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.73M in Q2 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Wealth Advisory Solutions held 25,231 shares of Pfizer worth $708K as of Q1 2026.
  • Wealth Advisory Solutions bought 1,336 Pfizer shares in Q1 2026, an estimated $35.6K.
  • Pfizer made up 0.16% of Wealth Advisory Solutions's portfolio in Q1 2026, its #80 holding.
  • Wealth Advisory Solutions first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
  • Wealth Advisory Solutions's Pfizer position peaked at $3.73M in Q2 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wealth Advisory Solutions's 13F filing for Q1 2026, filed 22 Apr 2026.